In the field of functional proteomics,the human disease proteomics shows great potential in the discovery of new molecular targets and biomarkers for medicine and biopharmacy.

其中,在功能蛋白质组领,病蛋白质组学在医学和生物制方面具有发现新分子靶、生物标志物的巨大的潜力。

Proteomics could also be vital to the future of the pharmaceutical industry, says Jessica Chutter, managing director and co-director of biotechnology for Morgan Stanley.

同时，根据摩根史坦利公司兼生物科技部门恰特的说法，蛋白组学对于制工业的前途也可能举足轻重。